- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT04735744
Evaluation of Allied Healthcare in Patients Recovering From COVID-19 (ParaCOV)
SUMMARY Rationale: Allied health professionals (i.e., dietitians, exercise therapists, physical therapists, occupational therapists and speech and language therapists) might play an important role in the recovery of patients with COVID-19 who experience limitations in daily physical functioning and participation. However, the evidence base for allied healthcare in patients with COVID-19 has yet to be established. To facilitate care for people recovering from COVID-19 and to establish this evidence base, the Dutch ministry has created a temporary regulation for primary care allied healthcare specifically for patients with COVID-19.
Objective: This study is setup alongside the temporary regulation and aims to evaluate the longitudinal recovery trajectories and related costs of patients who visited a primary care allied healthcare professional for the management of severe symptoms and activity limitations and/or participation restrictions related to COVID-19.
Study design: Prospective cohort study. Study population: 1,315 adult patients recovering from COVID-19 with severe symptoms and activity limitations and/or participation restrictions, and who are referred to a primary care allied health professional by a general practitioner or medical specialist within four months of the start of the disease will be eligible for this study.
Intervention (if applicable): Although the nature of this study is non-experimental, the allied healthcare intervention can be considered experimental due to the novelty of the disease.
Main study parameters/endpoints: The primary outcome domain of this study is participation measured with the Utrechtse Schaal voor Revalidatie - Participatie (USER-P). The primary endpoint is set at 6 months. A 5 point difference will be considered clinically relevant for patients with COVID-19.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: There are no specific risks involved with participation in this study, as it entails the completion of questionnaires over the timeframe of one year (at the start of the treatment, the end of the treatment, 3 months, 6 months, 9 months and 12 months). The load of the survey will be highest at months 3, 6 and 12 with a total of 74 survey items. Input from patient representatives suggested that this number of items was feasible, especially because participants are allowed to complete the survey over a number of days. Finally, none of the items in the survey are considered emotionally distressing. The prescribed interventions are conform the recommendations of the best available evidence and are in line with usual allied healthcare interventions. Therefore, risks are likely to be negligible conform usual allied healthcare.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Contatti e Sedi
Luoghi di studio
-
-
Gelderland
-
Nijmegen, Gelderland, Olanda, 6500HB
- Radboud university medical center
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Adult patients of 18 year and older recovering from COVID-19 with severe symptoms and activity limitations and/or participation restrictions, who are referred to a primary care allied health professional* by a general practitioner or medical specialist are deemed eligible for this study.
*Allied health professionals relevant to this study are: Dietitians, Exercise Therapists, Occupational Therapists, Physical Therapists, and Speech and Language Therapists working in primary care in the Netherlands.
Descrizione
Inclusion Criteria:
Adult patients
- recovering from COVID-19 with severe symptoms and activity limitations and/or participation restrictions, and;
- who are referred to a primary care allied health professional by a general practitioner or medical specialist within four months of the start of the disease; will be eligible for this study. The need for referring the patient to an allied health professional will be judged by the primary care physician or medical specialist. Criteria for referral are described in guidance published by the Long Alliantie Nederland (LAN) with recommendations for treatment of post-COVID-19-patients: the COVID-19 Associated Syndrome (CAS) (Chapters 3.3 and 4).
http://www.longalliantie.nl/files/2515/9359/4621/Handreiking_voor_de_zorg.pdf
Exclusion Criteria:
Adult patients:
- receiving palliative care; are excluded from this study.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
Intervento / Trattamento |
---|---|
Prospective cohort
Allied health professionals (i.e., dietitians, exercise therapists, physical therapists, occupational therapists and speech and language therapists) that treat patients recovering from COVID-19 in Dutch primary care
|
We will not develop specific interventions for this prospective observational cohort study.
The care provided by allied health professionals in daily practice are based on recommendations published by the professional bodies of allied health professionals and on the interdisciplinary guidance developed by the LAN.
All allied health professionals are working according to these recommendations.
Dissemination of these recommendations is done by the professional bodies of the allied health professionals.
Given the observational nature of our study, no additional implementation strategies will be employed to stimulate this care by the research group.
|
Retrospective cohort
Allied health professionals (i.e., dietitians, exercise therapists, physical therapists, occupational therapists and speech and language therapists) that have been treated patients recovering from COVID-19 in Dutch primary care
|
We will not develop specific interventions for this prospective observational cohort study.
The care provided by allied health professionals in daily practice are based on recommendations published by the professional bodies of allied health professionals and on the interdisciplinary guidance developed by the LAN.
All allied health professionals are working according to these recommendations.
Dissemination of these recommendations is done by the professional bodies of the allied health professionals.
Given the observational nature of our study, no additional implementation strategies will be employed to stimulate this care by the research group.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Participation
Lasso di tempo: Baseline (T0)
|
Measured with the Utrecht Scale for Evaluation of Rehabilitation Participation (USER-P) (32 items)
|
Baseline (T0)
|
Participation
Lasso di tempo: 3 months (T1)
|
Measured with the Utrecht Scale for Evaluation of Rehabilitation Participation (USER-P) (32 items)
|
3 months (T1)
|
Participation
Lasso di tempo: 6 months (T2)
|
Measured with the Utrecht Scale for Evaluation of Rehabilitation Participation (USER-P) (32 items)
|
6 months (T2)
|
Participation
Lasso di tempo: 12 months (T3)
|
Measured with the Utrecht Scale for Evaluation of Rehabilitation Participation (USER-P) (32 items)
|
12 months (T3)
|
Quality of life measured with EQ-5D-5L
Lasso di tempo: Baseline (T0)
|
Measured with the EuroQol five-dimensional questionnaire (EQ-5D-5L) (5 items)
|
Baseline (T0)
|
Quality of life measured with EQ-5D-5L
Lasso di tempo: 3 months (T1)
|
Measured with the EuroQol five-dimensional questionnaire (EQ-5D-5L) (5 items)
|
3 months (T1)
|
Quality of life measured with EQ-5D-5L
Lasso di tempo: 6 months (T2)
|
Measured with the EuroQol five-dimensional questionnaire (EQ-5D-5L) (5 items)
|
6 months (T2)
|
Quality of life measured with EQ-5D-5L
Lasso di tempo: 12 months (T3)
|
Measured with the EuroQol five-dimensional questionnaire (EQ-5D-5L) (5 items)
|
12 months (T3)
|
Fatigue
Lasso di tempo: Baseline (T0)
|
Measured with the Fatigue Severity Scale (FSS)
|
Baseline (T0)
|
Fatigue
Lasso di tempo: 3 months (T1)
|
Measured with the Fatigue Severity Scale (FSS)
|
3 months (T1)
|
Fatigue
Lasso di tempo: 6 months (T2)
|
Measured with the Fatigue Severity Scale (FSS)
|
6 months (T2)
|
Fatigue
Lasso di tempo: 12 months (T3)
|
Measured with the Fatigue Severity Scale (FSS)
|
12 months (T3)
|
Physical functioning
Lasso di tempo: Baseline (T0)
|
PROMIS Physical Functioning Short Form 10b (10 items).
|
Baseline (T0)
|
Physical functioning
Lasso di tempo: 3 months (T1)
|
PROMIS Physical Functioning Short Form 10b (10 items).
|
3 months (T1)
|
Physical functioning
Lasso di tempo: 6 months (T2)
|
PROMIS Physical Functioning Short Form 10b (10 items).
|
6 months (T2)
|
Physical functioning
Lasso di tempo: 12 months (T3)
|
PROMIS Physical Functioning Short Form 10b (10 items).
|
12 months (T3)
|
Costs
Lasso di tempo: Baseline (T0)
|
will be measured using a cost questionnaire (18 items)
|
Baseline (T0)
|
Costs
Lasso di tempo: 3 months (T1)
|
will be measured using a cost questionnaire (18 items)
|
3 months (T1)
|
Costs
Lasso di tempo: 6 months (T2)
|
will be measured using a cost questionnaire (18 items)
|
6 months (T2)
|
Costs
Lasso di tempo: 9 months (T3)
|
will be measured using a cost questionnaire (18 items)
|
9 months (T3)
|
Costs
Lasso di tempo: 12 months (T4)
|
will be measured using a cost questionnaire (18 items)
|
12 months (T4)
|
Patient Specific Activities
Lasso di tempo: baseline (T0) as part of usual care
|
measured with the Patient Specific Complaints (PSC)
|
baseline (T0) as part of usual care
|
Patient Specific Activities
Lasso di tempo: end of the treatment as part of usual care (average of 6 months)
|
measured with the Patient Specific Complaints (PSC)
|
end of the treatment as part of usual care (average of 6 months)
|
Nutritional Status
Lasso di tempo: baseline (T0) as part of usual care
|
measured with the BMI (weight and height)
|
baseline (T0) as part of usual care
|
Nutritional Status
Lasso di tempo: end of the treatment as part of usual care (average of 6 months)
|
measured with the BMI (weight and height)
|
end of the treatment as part of usual care (average of 6 months)
|
Global Assessment
Lasso di tempo: baseline (T0) as part of usual care
|
measured with the PG-SGA short form weight history, food intake, symptoms, activities and function).
|
baseline (T0) as part of usual care
|
Global Assessment
Lasso di tempo: end of the treatment as part of usual care (average of 6 months)
|
measured with the PG-SGA short form weight history, food intake, symptoms, activities and function).
|
end of the treatment as part of usual care (average of 6 months)
|
Voice Problems
Lasso di tempo: baseline (T0) as part of usual care
|
measured with Voice Handicap Index (VHI)
|
baseline (T0) as part of usual care
|
Voice Problems
Lasso di tempo: end of the treatment as part of usual care (average of 6 months)
|
measured with Voice Handicap Index (VHI)
|
end of the treatment as part of usual care (average of 6 months)
|
Swallowing Problems
Lasso di tempo: baseline (T0) as part of usual care
|
Dysphagia Handicap Index (DHI).
|
baseline (T0) as part of usual care
|
Swallowing Problems
Lasso di tempo: end of the treatment as part of usual care (average of 6 months)
|
Dysphagia Handicap Index (DHI).
|
end of the treatment as part of usual care (average of 6 months)
|
Patient Specific Activities
Lasso di tempo: baseline (T0) as part of usual care
|
measured with the Canadian Occupational Performance Measure (COPM)
|
baseline (T0) as part of usual care
|
Patient Specific Activities
Lasso di tempo: end of the treatment as part of usual care (average of 6 months)
|
measured with the Canadian Occupational Performance Measure (COPM)
|
end of the treatment as part of usual care (average of 6 months)
|
Activities
Lasso di tempo: baseline (T0) as part of usual care
|
measured with the PRO-ergo
|
baseline (T0) as part of usual care
|
Activities
Lasso di tempo: end of the treatment as part of usual care (average of 6 months)
|
measured with the PRO-ergo
|
end of the treatment as part of usual care (average of 6 months)
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Exercise capacity
Lasso di tempo: baseline (T0) as part of usual care
|
6 Minute Walk Test (6MWT)
|
baseline (T0) as part of usual care
|
Exercise capacity
Lasso di tempo: end of the treatment as part of usual care (average of 6 months)
|
6 Minute Walk Test (6MWT)
|
end of the treatment as part of usual care (average of 6 months)
|
Exercise capacity
Lasso di tempo: baseline (T0) as part of usual care
|
Short Physical Performance Battery (SPPB)
|
baseline (T0) as part of usual care
|
Exercise capacity
Lasso di tempo: end of the treatment as part of usual care (average of 6 months)
|
Short Physical Performance Battery (SPPB)
|
end of the treatment as part of usual care (average of 6 months)
|
Quadriceps strength
Lasso di tempo: baseline (T0) as part of usual care
|
with a hand dynamometer.
|
baseline (T0) as part of usual care
|
Quadriceps strength
Lasso di tempo: end of the treatment as part of usual care (average of 6 months)
|
with a hand dynamometer.
|
end of the treatment as part of usual care (average of 6 months)
|
Hand grip strength
Lasso di tempo: baseline (T0) as part of usual care
|
with a hand dynamometer.
|
baseline (T0) as part of usual care
|
Hand grip strength
Lasso di tempo: end of the treatment as part of usual care (average of 6 months)
|
with a hand dynamometer.
|
end of the treatment as part of usual care (average of 6 months)
|
Bioimpedance (BIA
Lasso di tempo: baseline (T0) as part of usual care
|
baseline (T0) as part of usual care
|
|
Bioimpedance (BIA
Lasso di tempo: end of the treatment as part of usual care (average of 6 months)
|
end of the treatment as part of usual care (average of 6 months)
|
|
VAS-appetite, taste and smell
Lasso di tempo: baseline (T0) as part of usual care
|
baseline (T0) as part of usual care
|
|
VAS-appetite, taste and smell
Lasso di tempo: end of the treatment as part of usual care (average of 6 months)
|
end of the treatment as part of usual care (average of 6 months)
|
|
Dietary goal attainment
Lasso di tempo: baseline (T0) as part of usual care
|
baseline (T0) as part of usual care
|
|
Dietary goal attainment
Lasso di tempo: end of the treatment as part of usual care (average of 6 months)
|
end of the treatment as part of usual care (average of 6 months)
|
|
Liquid medical nutrition
Lasso di tempo: baseline (T0) as part of usual care
|
baseline (T0) as part of usual care
|
|
Liquid medical nutrition
Lasso di tempo: end of the treatment as part of usual care (average of 6 months)
|
end of the treatment as part of usual care (average of 6 months)
|
|
Sarcopenia
Lasso di tempo: baseline (T0) as part of usual care
|
measured with the SARC-F
|
baseline (T0) as part of usual care
|
Sarcopenia
Lasso di tempo: end of the treatment as part of usual care (average of 6 months)
|
measured with the SARC-F
|
end of the treatment as part of usual care (average of 6 months)
|
Types of Stool
Lasso di tempo: baseline (T0) as part of usual care
|
measured with the Bristol Stool Chart (BCS)
|
baseline (T0) as part of usual care
|
Types of Stool
Lasso di tempo: end of the treatment as part of usual care (average of 6 months)
|
measured with the Bristol Stool Chart (BCS)
|
end of the treatment as part of usual care (average of 6 months)
|
Voice Problems
Lasso di tempo: baseline (T0) as part of usual care
|
measured with Maximum Phonation Time (MPT)
|
baseline (T0) as part of usual care
|
Voice Problems
Lasso di tempo: end of the treatment as part of usual care (average of 6 months)
|
measured with Maximum Phonation Time (MPT)
|
end of the treatment as part of usual care (average of 6 months)
|
Swallowing Problems
Lasso di tempo: baseline (T0) as part of usual care
|
measured with Maximum Swallowing Speed (MSP)
|
baseline (T0) as part of usual care
|
Swallowing Problems
Lasso di tempo: end of the treatment as part of usual care (average of 6 months)
|
measured with Maximum Swallowing Speed (MSP)
|
end of the treatment as part of usual care (average of 6 months)
|
Physical Functioning
Lasso di tempo: baseline (T0) as part of usual care
|
measured with the Assessment of Motor and Process Skills (AMPS)
|
baseline (T0) as part of usual care
|
Physical Functioning
Lasso di tempo: end of the treatment as part of usual care (average of 6 months)
|
measured with the Assessment of Motor and Process Skills (AMPS)
|
end of the treatment as part of usual care (average of 6 months)
|
Cognitive Functioning
Lasso di tempo: baseline (T0) as part of usual care
|
measured with the Cognitive Complaints - Participation (CoCo-P)
|
baseline (T0) as part of usual care
|
Cognitive Functioning
Lasso di tempo: end of the treatment as part of usual care (average of 6 months)
|
measured with the Cognitive Complaints - Participation (CoCo-P)
|
end of the treatment as part of usual care (average of 6 months)
|
Collaboratori e investigatori
Investigatori
- Investigatore principale: Philip van der Wees, Prof. dr., Radboud university medical center
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Anticipato)
Completamento dello studio (Anticipato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- ParaCOV
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Covid19
-
Anavasi DiagnosticsNon ancora reclutamento
-
Ain Shams UniversityReclutamento
-
Israel Institute for Biological Research (IIBR)Completato
-
Colgate PalmoliveCompletato
-
Christian von BuchwaldCompletato
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdAttivo, non reclutante
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitätsspital ZürichIscrizione su invito
-
Alexandria UniversityCompletato